Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kangbingdu Granules
- Development stage
- Unknown
- Lead developer
- China-Japan Friendship Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Kangbingdu Granules is a Traditional Chinese Medicine (TCM) formulation widely used in China for the treatment of upper respiratory tract infections, including influenza and the common cold. Developed in collaboration with institutions like the China-Japan Friendship Hospital, the formula typically consists of several herbal ingredients such as *Radix Isatidis*, *Rhizoma Phragmitis*, and *Radix Rehmanniae*. It is characterized by its heat-clearing, detoxifying, and blood-cooling properties. Mechanistically, it is believed to exert broad-spectrum antiviral effects, inhibit inflammatory cytokines, and modulate the immune response, although specific molecular targets are often multi-faceted due to its complex herbal composition. It is primarily indicated for symptoms like fever, sore throat, and cough associated with viral infections.
- Brand names
- XiangxueKangbingdu Keli
- Other names
- Anti-viral GranulesKangbingdu Keli
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))NeuraminidaseIL-6 (Interleukin 6)
Beyond the preview
Go deeper on Kangbingdu Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kangbingdu Granules.